Tirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report
Abstract
Tirzepatide has demonstrated efficacy in multiple domains of metabolic health, such as weight loss, glycemic control, and improvement of metabolic dysfunction-associated steatotic liver disease (MASLD). Despite this, tirzepatide remains understudied and underutilized in the military population. We report a case of a 29-year-old active-duty male with newly diagnosed type 2 diabetes mellitus (T2DM), class II obesity (BMI 35.6 kg/m²), dyslipidemia, and MASLD who experienced marked improvement across multiple metabolic domains over approximately 12 months of tirzepatide-based treatment. This case highlights that a comprehensive treatment approach, including tirzepatide, lifestyle modifications, and adjunctive pharmacotherapy, was associated with substantial multidomain metabolic improvement in young active duty service members (ADSM). Further studies are needed to determine whether these findings translate into broader benefits for military readiness, retention, and healthcare utilization within the Military Health System (MHS).
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.